Loading market data...
Tue, 20 Oct 2026
03:28:28 pm
Tue, 20 Oct 2026
03:28:28 pm
Synopsis
Laurus Labs share price rises 2.25% to ₹2,064 on October 16, 2026, near its 52 week high of ₹2,086. Check stock returns and quarterly results.
Laurus Labs shares rose 2.25% to ₹2,064 on the NSE at 12:22 PM IST on October 16, 2026.
The stock traded close to its 52 week high of ₹2,086, compared with its 52 week low of ₹870.45. Shares have gained 136.57% in one year.
| Metric | Details |
|---|---|
| Current price | ₹2,064 |
| Daily change | +2.25% |
| Intraday high | ₹2,086 |
| Intraday low | ₹2,028.70 |
| 52 week high | ₹2,086 |
| 52 week low | ₹870.45 |
| Market capitalisation | ₹1,12,112.59 crore |
| P/E ratio | 102.48 |
| Period | Return |
|---|---|
| 1 week | +1.39% |
| 1 month | +8.37% |
| 3 months | +32.57% |
| 1 year | +136.57% |
| 3 years | +417.91% |
| 5 years | +217.19% |
Laurus Labs reported June 2026 quarterly net profit of ₹367.60 crore, up from ₹279.14 crore in March 2026. Total income increased to ₹2,035.49 crore from ₹1,823.37 crore in the previous quarter.
The average recommendation from 12 analysts is Hold, based on the supplied data.
Market data is as of 12:22 PM IST on October 16, 2026. This article is for informational purposes only and is not investment advice.
Laurus Labs shares traded at ₹2,064 on the NSE as of 12:22 PM IST on October 16, 2026, up 2.25% for the day.
Laurus Labs' 52-week high is ₹2,086, while its 52-week low is ₹870.45, according to the supplied data.
The stock gained 136.57% over one year, based on the supplied market data.
The stock rose 2.25% during the reported session and traded near its 52-week high. The supplied data does not establish a specific reason for the rise.
Laurus Labs' reported market capitalisation was approximately ₹1,12,112.59 crore.
The stock's reported price-to-earnings (P/E ratio) was 102.48.
Laurus Labs reported net profit of ₹367.60 crore for the quarter ended June 2026, compared with ₹279.14 crore in the March 2026 quarter, according to the supplied data.
The company's total income stood at ₹2,035.49 crore in June 2026, compared with ₹1,823.37 crore in the previous quarter.
The average recommendation from 12 analysts was Hold, based on the supplied data. Analyst opinions may change and do not guarantee future returns.
That depends on its valuation, earnings growth, business outlook, financial performance and an investor's risk tolerance. Investors may wish to assess the reported P/E ratio alongside future earnings expectations. Past returns and analyst recommendations do not guarantee future gains.
Financial journalist specializing in market analysis, stock research, and investment trends. Dedicated to providing accurate, timely insights for informed decision-making.
Credentials: Experienced financial journalist with expertise in equity markets and economic analysis
The information provided in this article is for educational and informational purposes only and should not be construed as financial, investment, or legal advice. welomoney does not provide personalized investment recommendations.
For detailed terms and conditions, please read our Disclaimer and Terms of Service.
L&T has begun preliminary work on the New Tashkent International Airport project after receiving a limited notice to proceed.
DLF share price has 41% upside, according to HSBC’s target. Compare Jefferies, CLSA and other broker views on sales, cash flow and valuations.
Divi's Laboratories shares rose 1.01% to Rs 9,242.50 after a positive EU opinion on Eli Lilly's weight loss drug Foundayo. See the growth outlook.
Awfis revenue target exceeds Rs 1,800 crore for FY27, with flexible workspace demand supporting growth. Expansion and execution remain key to watch.
L&T has won a contract worth over Rs 15,000 crore. The client, project scope and execution timeline remain undisclosed, leaving its revenue impact...
